Niimi A - Search Results

1

Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Kita N, Tomita N, Takaoka T, Matsuura A, Okazaki D, Niwa M, Torii A, Takano S, Mekata Y, Niimi A, Hiwatashi A. Kita N, et al. Among authors: niimi a. Clin Transl Radiat Oncol. 2023 Sep 25;43:100683. doi: 10.1016/j.ctro.2023.100683. eCollection 2023 Nov. Clin Transl Radiat Oncol. 2023. PMID: 37790583 Free PMC article.

2

Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer.

Kita N, Tomita N, Takaoka T, Sudo S, Tsuzuki Y, Okazaki D, Niwa M, Torii A, Takano S, Niimi A, Hiwatashi A. Kita N, et al. Among authors: niimi a. Cancers (Basel). 2023 Jan 31;15(3):887. doi: 10.3390/cancers15030887. Cancers (Basel). 2023. PMID: 36765844 Free PMC article.

3

Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Kita N, Tomita N, Takaoka T, Okazaki D, Niwa M, Torii A, Takano S, Mekata Y, Niimi A, Hiwatashi A. Kita N, et al. Among authors: niimi a. Clin Transl Radiat Oncol. 2023 Jun 2;41:100648. doi: 10.1016/j.ctro.2023.100648. eCollection 2023 Jul. Clin Transl Radiat Oncol. 2023. PMID: 37346273 Free PMC article.

4

Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients.

Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, Nakamura M, Kawakita D, Hamamoto S, Uemura T, Yokota K, Iida M, Odagiri K, Kimura Y, Hotta Y, Komatsu H, Okuda K, Niimi A, Yasui T, Iwasaki S, Morita A, Kataoka H, Takiguchi S, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: niimi a. Asia Pac J Clin Oncol. 2024 Aug;20(4):515-521. doi: 10.1111/ajco.14073. Epub 2024 Apr 29. Asia Pac J Clin Oncol. 2024. PMID: 38682421

5

Pulmonary Artery Pseudoaneurysm after Transbronchial Lung Cryobiopsy.

Hara Y, Ohkubo H, Fujita K, Niimi A. Hara Y, et al. Among authors: niimi a. Intern Med. 2024 May 1;63(9):1325-1326. doi: 10.2169/internalmedicine.2652-23. Epub 2023 Sep 15. Intern Med. 2024. PMID: 37722891 Free PMC article. No abstract available.

6

Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.

Tasaki Y, Sugiyama Y, Hamamoto S, Naiki T, Uemura T, Yokota K, Kawakita D, Nakamura M, Ogawa R, Shimura T, Mimura Y, Hotta Y, Odagiri K, Ito N, Iida M, Kimura Y, Komatsu H, Kataoka H, Takiguchi S, Morita A, Iwasaki S, Okuda K, Niimi A, Yasui T, Furukawa-Hibi Y. Tasaki Y, et al. Among authors: niimi a. Cancer Med. 2023 Dec;12(24):21666-21679. doi: 10.1002/cam4.6724. Epub 2023 Nov 21. Cancer Med. 2023. PMID: 37986680 Free PMC article.

7

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease triggered by COVID-19: What is the best practice for treatment?

Yonezawa T, Suzuki A, Fukumitsu K, Katano T, Kako H, Ishii M, Niimi A, Imaizumi K, Sakamoto K, Omote N, Yamaguchi E. Yonezawa T, et al. Among authors: niimi a. Respir Med Case Rep. 2023;43:101857. doi: 10.1016/j.rmcr.2023.101857. Epub 2023 Apr 25. Respir Med Case Rep. 2023. PMID: 37124053 Free PMC article.

8

Low Daily Step Count Associated with Small Erector Spinae Muscle Area and Sarcopenia in Idiopathic Pulmonary Fibrosis.

Ohkubo H, Fujita K, Ito K, Nakano A, Horiuchi M, Mori Y, Fukumitsu K, Fukuda S, Kanemitsu Y, Uemura T, Tajiri T, Ito Y, Ozawa Y, Murase T, Niimi A. Ohkubo H, et al. Among authors: niimi a. Intern Med. 2024 May 15;63(10):1345-1352. doi: 10.2169/internalmedicine.2584-23. Epub 2023 Oct 13. Intern Med. 2024. PMID: 37839878 Free PMC article.

9

High-dimensional analysis of T-cell profiling variations following belimumab treatment in systemic lupus erythematosus.

Maeda S, Hashimoto H, Maeda T, Tamechika SY, Isogai S, Naniwa T, Niimi A. Maeda S, et al. Among authors: niimi a. Lupus Sci Med. 2023 Oct;10(2):e000976. doi: 10.1136/lupus-2023-000976. Lupus Sci Med. 2023. PMID: 37802602 Free PMC article.

10

Effectiveness of remdesivir-based therapy for moderate COVID-19: comparison of Omicron and other variant phases.

Suzuki A, Fukumitsu K, Fukihara J, Katano T, Kako H, Maeda Y, Ishii M, Niimi A, Imaizumi K, Yamaguchi E. Suzuki A, et al. Among authors: niimi a. J Chemother. 2024 Apr;36(2):127-132. doi: 10.1080/1120009X.2023.2289268. Epub 2023 Dec 3. J Chemother. 2024. PMID: 38044564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

512 results

Search Page

Filters